{"altmetric_id":3360811,"counts":{"readers":{"mendeley":16,"citeulike":0,"connotea":0},"total":{"posts_count":1},"wikipedia":{"unique_users_count":1,"unique_users":["en:4402358"],"posts_count":1}},"citation":{"altmetric_jid":"4f6fa50a3cf058f610003160","authors":["Helen Pearson"],"doi":"10.1038\/news060313-17","first_seen_on":"2015-02-05T20:48:07+00:00","issns":["1744-7933","1476-4687"],"journal":"Nature","last_mentioned_on":1142772172,"links":["http:\/\/www.nature.com\/news\/2006\/060313\/full\/060313-17.html"],"pubdate":"2006-03-17T00:00:00+00:00","publisher":"Nature Publishing Group","scopus_subjects":["General"],"subjects":["science"],"title":"Tragic drug trial spotlights potent molecule","type":"news","mendeley_url":"http:\/\/www.mendeley.com\/research\/tragic-drug-trial-spotlights-potent-molecule"},"altmetric_score":{"score":3,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":3},"context_for_score":{"all":{"total_number_of_other_articles":3635501,"mean":4.9219382456039,"rank":816779,"this_scored_higher_than_pct":63,"this_scored_higher_than":2295908,"rank_type":"exact","sample_size":3635501,"percentile":63},"similar_age_3m":{"total_number_of_other_articles":94804,"mean":8.1615390863159,"rank":24731,"this_scored_higher_than_pct":72,"this_scored_higher_than":68982,"rank_type":"exact","sample_size":94804,"percentile":72},"this_journal":{"total_number_of_other_articles":34755,"mean":41.323318179202,"rank":22243,"this_scored_higher_than_pct":21,"this_scored_higher_than":7543,"rank_type":"exact","sample_size":34755,"percentile":21},"similar_age_this_journal_3m":{"total_number_of_other_articles":675,"mean":139.59594362018,"rank":648,"this_scored_higher_than_pct":2,"this_scored_higher_than":20,"rank_type":"exact","sample_size":675,"percentile":2}}},"demographics":{"users":{"mendeley":{"by_status":{"Researcher":5,"Student  > Doctoral Student":1,"Student  > Ph. D. Student":1,"Student  > Postgraduate":1,"Student  > Master":2,"Other":1,"Student  > Bachelor":4,"Professor":1},"by_discipline":{"Medicine and Dentistry":7,"Social Sciences":1,"Agricultural and Biological Sciences":6,"Computer Science":1,"Unspecified":1}}},"geo":{"mendeley":{"CA":1,"GB":2,"ZA":1}}},"posts":{"wikipedia":[{"title":"TGN1412","url":"http:\/\/en.wikipedia.org\/?diff=prev&oldid=44497160#altmetric_citation_1","license":"public","citation_ids":[3360811],"posted_on":"2006-03-19T12:42:52+00:00","summary":"Originally intended for the treatment of B cell chronic lymphocytic leukemia (B-CLL) and rheumatoid arthritis, TGN1412 is a humanised monoclonal antibody that not only binds to, but is a strong agonist for, the CD28 receptor of the immune system's T cells.","page_url":"http:\/\/en.wikipedia.org\/?curid=4402358","wiki_lang":"en","author":{"name":"Para82","url":"http:\/\/en.wikipedia.org\/wiki\/User:Para82"}}]}}